Related Experiment Video

Updated: Jul 14, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

[Diabetic cardiomyopathy]

Katashi Okoshi1, Julliano F Campos Guimarães, Bruno Paulino Di Muzio

  • 1Departamento de Clínica Médica, Faculdade de Medicina de Botucatu, UNESP, SP, Brazil. katashi@fmb.unesp.br

Arquivos Brasileiros De Endocrinologia E Metabologia
|May 17, 2007
PubMed

Insights

Diabetic cardiomyopathy, a heart condition in diabetes mellitus patients, involves hypertrophy and cell death. Early detection of diastolic dysfunction is possible before heart failure symptoms appear.

Area of Science:

  • Cardiology
  • Endocrinology
  • Pathology

Context:

  • Diabetic cardiomyopathy is a distinct myocardial disease linked to diabetes mellitus.
  • It is independent of vascular, valvular, or hypertensive heart disease.
  • Diabetes mellitus induces significant cardiac changes, including hypertrophy, necrosis, and apoptosis.

Purpose:

  • To elucidate the pathophysiology of diabetic cardiomyopathy.
  • To highlight the clinical manifestations and detection of diabetic cardiomyopathy.
  • To outline current treatment strategies for heart failure in this context.

Summary:

  • Diabetes mellitus triggers metabolic disturbances (hyperlipidemia, hyperglycemia, hyperinsulinemia) affecting cardiac metabolism.
  • These metabolic changes result in oxidative stress, interstitial fibrosis, myocyte death, and impaired calcium homeostasis.
  • Early asymptomatic diastolic dysfunction is detectable, with systolic dysfunction appearing later in heart failure progression.

Impact:

  • Understanding diabetic cardiomyopathy's pathophysiology is crucial for targeted therapeutic development.
  • Early detection of diastolic dysfunction can lead to timely interventions.
  • Standard heart failure guidelines apply, focusing on ventricular function for treatment.

More Related Videos

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model05:58

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model

Published on: April 18, 2025

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...